Why the study?
Does ATP or CaCl2 counteract bupivacaine-induced depression of myocardial contractility in an isolated rabbit right atrial model?
Does ATP or CaCl2 counteract bupivacaine-induced depression of myocardial contractility in an isolated rabbit right atrial model?
Inhibition of energy metabolism appears to be a major mechanism of bupivacaine cardiotoxicity, as ATP almost completely restores inotropic function in vitro.
Answers are grounded in this paper and cite their sources.
ATP nearly restores bupivacaine-depressed contractility in vitro; hypothesis-generating for energy metabolism mechanism, should not yet change practice.
Although several mechanisms have been proposed to explain bupivacaine cardiotoxicity, the predominant effect remains to be determined. In this study, we used an isolated rabbit right atrial model that reproduces the effects on inotropic and chronotropic functions induced by 0.5 micrograms/mL bupivacaine; then we tried to counteract these events by electrical stimulation or by addition of CaCl2 or adenosine triphosphate (ATP) to the bathing solution. Contractile force was dramatically depressed by bupivacaine alone (-68%), even when the preparation was paced (-59%). CaCl2 partially counteracted this decrease (-37%). Inotropic function was almost completely restored (-9%) when ATP was added before administration of bupivacaine. Inhibition of energy metabolism seems to be a major explanation for bupivacaine cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
Eledjam et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: